| Scmg Infectious Disease & Lyme Clinic | |
|
14 Woodruff Ave Ste 1 Narragansett RI 02882-3467 | |
| (401) 789-8543 | |
| (401) 782-8766 |
| Full Name | Scmg Infectious Disease & Lyme Clinic |
|---|---|
| Speciality | Internal Medicine |
| Location | 14 Woodruff Ave Ste 1, Narragansett, Rhode Island |
| Authorized Official Name and Position | Marcia T Polhemus (CONTROLLER) |
| Authorized Official Contact | 4017881974 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Scmg Infectious Disease & Lyme Clinic 100 Kenyon Ave Wakefield RI 02879-4216 Ph: (401) 788-3929 | Scmg Infectious Disease & Lyme Clinic 14 Woodruff Ave Ste 1 Narragansett RI 02882-3467 Ph: (401) 789-8543 |
| NPI Number | 1386905313 |
|---|---|
| Provider Enumeration Date | 06/06/2012 |
| Last Update Date | 02/10/2022 |
| Medicare PECOS PAC ID | 4688661127 |
|---|---|
| Medicare Enrollment ID | O20121011000237 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers.
The student loan issue has become a politically charged showdown with the health law in the middle of the controversy.
Cosmetic surgery has always been fraught with unrealistic demands and sometimes legal action in cases of dissatisfactory results. Tens of thousands of cosmetic surgeries are performed each year and the numbers are climbing fast. A new study shows that Australian women who volunteer for cosmetic surgeries often have such unrealistic expectations for the outcomes of the surgeries.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386905313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | (* (Not Available)) | Primary |
| Provider Name | Brian D Cilley |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1760668487 PECOS PAC ID: 3173656667 Enrollment ID: I20120227000817 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers.
The student loan issue has become a politically charged showdown with the health law in the middle of the controversy.
Cosmetic surgery has always been fraught with unrealistic demands and sometimes legal action in cases of dissatisfactory results. Tens of thousands of cosmetic surgeries are performed each year and the numbers are climbing fast. A new study shows that Australian women who volunteer for cosmetic surgeries often have such unrealistic expectations for the outcomes of the surgeries.
› Verified 8 days ago
| Provider Name | Frederick A Browne |
|---|---|
| Provider Type | Practitioner - Infectious Disease |
| Provider Identifiers | NPI Number: 1588641955 PECOS PAC ID: 1456335900 Enrollment ID: I20121008000178 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers.
The student loan issue has become a politically charged showdown with the health law in the middle of the controversy.
Cosmetic surgery has always been fraught with unrealistic demands and sometimes legal action in cases of dissatisfactory results. Tens of thousands of cosmetic surgeries are performed each year and the numbers are climbing fast. A new study shows that Australian women who volunteer for cosmetic surgeries often have such unrealistic expectations for the outcomes of the surgeries.
› Verified 8 days ago
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Isis Pharmaceuticals, Inc. announced the initiation of a Phase 2 study evaluating ISIS-FXIRx in patients with end-stage renal disease (ESRD) on hemodialysis. In May 2015, Isis entered into an exclusive license agreement with Bayer HealthCare (Bayer) to develop and commercialize ISIS-FXIRx for the prevention of clotting disorders.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the rigorous FDA approval process is creating major hurdles for percutaneous heart valve device manufacturers.
The student loan issue has become a politically charged showdown with the health law in the middle of the controversy.
Cosmetic surgery has always been fraught with unrealistic demands and sometimes legal action in cases of dissatisfactory results. Tens of thousands of cosmetic surgeries are performed each year and the numbers are climbing fast. A new study shows that Australian women who volunteer for cosmetic surgeries often have such unrealistic expectations for the outcomes of the surgeries.
› Verified 8 days ago
Chiropractic Center Of South County,inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: Executive Bldg, 118 Point Judith Rd, Narragansett, RI 02882 Phone: 401-783-2937 Fax: 401-782-3620 | |
Silver Spring Health Care Management, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 14 Woodruff Ave Ste 1, Narragansett, RI 02882 Phone: 401-789-8543 Fax: 401-782-8766 | |
South County Walk In And Primary Care, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 360 Kingstown Rd, Suite 104, Narragansett, RI 02882 Phone: 401-789-1086 Fax: 401-789-5344 | |
Stephen Maguire Do Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 360 Kingstown Rd, Narragansett, RI 02882 Phone: 401-783-6940 | |
Kenneth J. Hathaway Do, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 360 Kingstown Rd, Suite 101, Narragansett, RI 02882 Phone: 401-783-3334 Fax: 401-783-9270 |